Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Original Article


Article page

447-451


Authors Details

Anitha Venugopal*, Meenakshi Ravindran, Ramakrishnan Rengappa, Aditya Ghorpade


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1239

PDF Downloaded: 639


Outcomes of Descemet’s stripping endothelial keratoplasty in patients with secondary glaucoma


Original Article

Author Details : Anitha Venugopal*, Meenakshi Ravindran, Ramakrishnan Rengappa, Aditya Ghorpade

Volume : 5, Issue : 4, Year : 2019

Article Page : 447-451

https://doi.org/10.18231/j.ijceo.2019.107



Suggest article by email

Get Permission

Abstract

Introduction: Aim of the study is to analyse the outcomes of Descemet’s stripping endothelial keratoplasty
(DSEK) for corneal oedema in patients with secondary glaucoma. Our’s is retrospective review of the
outcomes of DSEK that was performed for corneal decompensation in patients with secondary glaucoma.
Materials and Methods: A total of 93 patients, of which 17 had been diagnosed with secondary glaucoma,
were included in the study. All patients underwent medical or surgical treatment to control intraocular
pressure (IOP) before DSEK. The clinical outcomes of DSEK in these patients were evaluated. The
data collected included demographic patterns, indications, medical or surgical treatment for glaucoma,
intra-operative and post-operative complications of DSEK, IOP changes before and after DSEK, and
post-operative visual outcomes. The data were analysed based on the different aetiologies of secondary
glaucoma such as iridocorneal endothelial (ICE) syndrome, pseudoexfoliation (PXF) syndrome, glaucoma
in pseudophakia, traumatic glaucoma, and inflammatory glaucoma. The average IOP of each patient was
calculated using both applanation tonometry and Tono-pen before and after DSEK and at every follow-up.
Main Outcome Measures Graft clarity, IOP changes, and visual outcomes after DSEK were evaluated for all patients.
Results: DSEK was performed for the following causes of secondary glaucoma in descending order: PXF,
6 patients; ICE, 4 patients; glaucoma in pseudophakia, 3 patients; traumatic glaucoma, 2 patients; and
inflammatory glaucoma, 2 patients. Two patients underwent trabeculectomy, 5 patients underwent aqueous
tube drainage surgery, and 13 patients were administered medication before DSEK. At the 1-year followup,
14 patients had clear grafts with best corrected visual acuity (BCVA) scores greater than 6/36, while
the BCVA scores of the other 3 patients were below 6/60.
Conclusion: DSEK is an appropriate method for treating all types of secondary glaucoma. After DSEK,
the visual recovery, refractive outcomes are superior and the rise in IOP is minimal compared to those after
Full thickness Keratoplasty, since the angle anatomy and corneal contour is maintained.

Keywords: Descemet’s membrane endothelial keratoplasty, Secondary glaucoma.


How to cite : Venugopal A, Ravindran M, Rengappa R, Ghorpade A, Outcomes of Descemet’s stripping endothelial keratoplasty in patients with secondary glaucoma. Indian J Clin Exp Ophthalmol 2019;5(4):447-451

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.